Clinical Trials Directory

Trials / Unknown

UnknownNCT05109676

Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer.

Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer: a Population Pharmacokinetic Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

During an In Vitro Fertilization (IVF) attempt, several embryos are obtained but not all of them can be transferred to the uterus in the same cycle due to the risk of multiple pregnancies. Thus, it is very common for these couples to benefit from cryopreservation. Patients scheduled for frozen embryo transfer (TEC) receive estrogen and progesterone replacement therapy to prepare the endometrium for implantation. Data from the literature recently showed that low progesterone on the day of embryo transfer was responsible for a significantly higher rate of implantation failure and miscarriage.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireA questionnaire will be offered to patients and identify the schedules of administration of progesterone, the day and time of blood samples taken as part of the care, the potential adverse events associated with this administration.

Timeline

Start date
2021-12-07
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2021-11-05
Last updated
2022-11-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05109676. Inclusion in this directory is not an endorsement.